{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:23:16Z","timestamp":1785198196424,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T14:08:24Z","timestamp":1553004504000},"page":"2311-2321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A systematic review of vaccine preventable disease surveillance cost studies"],"prefix":"10.1016","volume":"37","author":[{"given":"Ngozi Adaeze","family":"Erondu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ferland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betiel Hadgu","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo","family":"Abimbola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7080","key":"10.1016\/j.vaccine.2019.02.026_b0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/440006a","article-title":"Disease surveillance needs a revolution","volume":"440","author":"Butler","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.02.026_b0010","unstructured":"World Health Organization. Strengthening immunization to achieve the goals of the global vaccine action plan draft resolution from the The Seventieth World Health Assembly. A70\/A\/CONF.\/1 2017. Available from: <http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA70\/A70_ACONF1-en.pdf?ua=1&ua=1>."},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.026_b0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/eurpub\/ckv250","article-title":"Economic Evaluations of public health surveillance systems: a systematic review","volume":"26","author":"Herida","year":"2016","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.vaccine.2019.02.026_b0020","doi-asserted-by":"crossref","unstructured":"Tandon A, Cashin C. Assessing public expenditure on health from a fiscal space perspective HNP discussion paper; 2010 [cited 2018 Oct 1]. Available from: <www.worldbank.org\/hnppublications>.","DOI":"10.1596\/13613"},{"key":"10.1016\/j.vaccine.2019.02.026_b0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/oxfordjournals.epirev.a036021","article-title":"Public health surveillance in the United States","volume":"10","author":"Thacker","year":"1988","journal-title":"Epidemiol Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.026_b0030","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.02.026_b0035","unstructured":"Critical Appraisal Skills. Critical Appraisal Skills Programme (CASP): Economic evaluation checklist Oxford; 2017. Available from: <http:\/\/docs.wixstatic.com\/ugd\/dded87_861b48c94b654b82a84250ca684d9186.pdf>."},{"key":"10.1016\/j.vaccine.2019.02.026_b0040","unstructured":"Erondu NA. Evaluating communicable disease surveillance in resource-poor settings: a new approach applied to meningitis surveillance in Chad London school of hygiene and tropical medicine; 2015. Available from: <http:\/\/researchonline.lshtm.ac.uk\/2603680\/1\/2015_PHP_PHD_Erondu_N.pdf>."},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.026_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-3156.2011.02881.x","article-title":"Costs of dengue prevention and incremental cost of dengue outbreak control in Guantanamo","volume":"17","author":"Baly","year":"2012","journal-title":"Cuba. Trop Med Int Heal"},{"key":"10.1016\/j.vaccine.2019.02.026_b0050","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1539-6924.2006.00842.x","article-title":"The costs of future polio risk management policies","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2019.02.026_b0055","doi-asserted-by":"crossref","first-page":"C88","DOI":"10.1016\/j.vaccine.2013.05.036","article-title":"Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica","volume":"31","author":"Toscano","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2019.02.026_b0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.vaccine.2015.10.045","article-title":"The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger","volume":"34","author":"Irurzun-Lopez","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.026_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2410-0","article-title":"Evaluation of the enhanced meningitis surveillance system, Yendi municipality, northern Ghana, 2010\u20132015","volume":"17","author":"Kaburi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.026_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.05.038","article-title":"Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization","volume":"31","author":"Casta\u00f1eda-Orjuela","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.026_b0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/heapol\/czs022","article-title":"The implementation of Integrated Disease Surveillance and Response in Uganda: a review of progress and challenges between 2001 and 2007","volume":"28","author":"Lukwago","year":"2013","journal-title":"Health Policy Plan"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.026_b0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2875-8-17","article-title":"Costs of early detection systems for epidemic malaria in highland areas of Kenya and Uganda","volume":"8","author":"Mueller","year":"2009","journal-title":"Malar J"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.026_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-7-1","article-title":"Cost analysis of an integrated disease surveillance and response system: Case of Burkina Faso, Eritrea, and Mali","volume":"7","author":"Somda","year":"2009","journal-title":"Cost Eff Resour Alloc"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.02.026_b0090","doi-asserted-by":"crossref","first-page":"A40","DOI":"10.1016\/j.vaccine.2014.12.081","article-title":"Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana","volume":"33","author":"Le Gargasson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.026_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1112-8","article-title":"An economic analysis of poliovirus risk management policy options for 2013\u20132052","author":"Duintjer Tebbens","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.02.026_b0100","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1016\/j.vaccine.2014.12.066","article-title":"Costs and financing of routine immunization: approach and selected findings of a multi-country study (EPIC)","volume":"33","author":"Brenzel","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.026_b0105","unstructured":"Somda ZC, Meltzer M, Perry HN. SurvCost 1.0: a manual to assist country and district public health officials in estimating the cost of the implementation of Integrated Disease Surveillance and Response systems (Beta test version) Atlanta, USA; 2007. Available from: <https:\/\/www.cdc.gov\/globalhealth\/healthprotection\/idsr\/resources.html>."},{"key":"10.1016\/j.vaccine.2019.02.026_b0110","unstructured":"Bureau of Labor Statistics. BLS-Historical Consumer Price Index for All items; All Urban Consumers (CPI-U): U.S. city average Washington, DC; 2017 [cited 2018 Feb 16]. Available from: <https:\/\/www.bls.gov\/cpi\/detailed-report.htm>."},{"key":"10.1016\/j.vaccine.2019.02.026_b0115","unstructured":"World Health Organization. Communicable disease surveillance and response systems Geneva; 2006 [cited 2018 Feb 12]. Available from: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/69331\/1\/WHO_CDS_EPR_LYO_2006_2_eng.pdf>."},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.026_b0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1478-4505-9-27","article-title":"Strengthening systems for communicable disease surveillance: creating a laboratory network in Rwanda","volume":"2011","author":"Kebede","year":"2011","journal-title":"Heal Res Policy Syst"},{"key":"10.1016\/j.vaccine.2019.02.026_b0125","unstructured":"World Health Organization. Immunization costing & financing: a tool and user guide for comprehensive multi-year planning (cMYP) Geneva, Switzerland; 2006. Available from: <http:\/\/apps.who.int\/iris\/handle\/10665\/69625>."},{"key":"10.1016\/j.vaccine.2019.02.026_b0130","unstructured":"Agence de Medecine Preventive, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (U.S.), Center for Health Decision Science at Harvard School of Public Health. ProVac: Promotion of evidence-based decision making for the introduction of new vaccines [cited 2018 Mar 16]. Available from: <http:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=13239&Itemid=841>."},{"key":"10.1016\/j.vaccine.2019.02.026_b0135","unstructured":"World Health Organisation. WHO\u2013recommended standards for surveillance of selected vaccine-preventable diseases Geneva; 2008 [cited 2018 Feb 15]. Available from: <http:\/\/apps.who.int\/iris\/bitstream\/10665\/68334\/1\/WHO_V-B_03.01_eng.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:46Z","timestamp":1759401106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1930221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X1930221X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of vaccine preventable disease surveillance cost studies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}